Literature DB >> 19809557

Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.

Kidong Kim1, Sang-Young Ryu.   

Abstract

Entities:  

Year:  2009        PMID： 19809557      PMCID： PMC2757568          DOI： 10.3802/jgo.2009.20.3.198

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  2 in total

Review 1.  Surgical management of recurrent ovarian cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929

2.  Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.

Authors:  Jaeman Bae; Myong Cheol Lim; Jae-Ho Choi; Yong-Joong Song; Kyoung-Soo Lee; Sokbom Kang; Sang-Soo Seo; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401
  2 in total
  3 in total

1.  Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.

Authors:  Min Kyu Kim; Chang Ohk Sung; In-Gu Do; Hye-Kyung Jeon; Tae Jong Song; Hwang Shin Park; Yoo-Young Lee; Byoung-Gie Kim; Jeong-Won Lee; Duk-Soo Bae
Journal:  Int J Clin Oncol       Date:  2011-02-16       Impact factor: 3.402

2.  Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer.

Authors:  Xia Xu; Xiaoxiang Chen; Zhiqin Dai; Fei Deng; Junwei Qu; Jing Ni
Journal:  J Exp Clin Cancer Res       Date:  2013-09-02

3.  The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial.

Authors:  Hongyuan Gu; Rui Zhou; Jing Ni; Xia Xu; Xianzhong Cheng; Yan Li; Xiaoxiang Chen
Journal:  J Ovarian Res       Date:  2020-06-16       Impact factor: 4.234
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.